# Coherus Lowers Quarterly LOQTORZI Revenue Needed for Core Cash Burn

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/53628
Published: 2026-11-11T06:08:12.000Z
Updated: 2026-11-11T06:08:12.000Z
Section: Business

> The new range is $25 million to $30 million per quarter. Coherus expects core cash burn to fall by $6 million to $7 million per quarter, with benefits realized over the next two quarters.

Coherus Oncology lowered the quarterly LOQTORZI revenue needed to cover core cash burn to $25 million to $30 million and expects a $6 million to $7 million quarterly decline in core cash burn.

The previous threshold was $30 million to $35 million per quarter.

Coherus expects the benefits to be realized over the next two quarters.